Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Ussing chambers for the study of nanoparticle permeability in the human jejunum

  • In: Poster Presentation
  • At: Stockholm (Sweden) (2017)
  • Type: Poster
  • Poster code: P-B-029-Tuesday
  • By: LUNDQUIST, Patrik (Uppsala University, Pharmacy, Uppsala, Sweden)
  • Co-author(s): Patrik Lundquist: Department of Pharmacy, Uppsala University, Uppsala, Sweden
    Georgiy Khodus: Department of Pharmacy, Uppsala University, Uppsala, Sweden
    Ivailo Simoff: Department of Pharmacy, Uppsala University, Uppsala, Sweden
    Lungile Thwala: Dept. of Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Santiago de Compostela, Spain
    Zhigao Niu: Dept. of Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Santiago de Compostela, Spain
    Dominic-Luc Webb: Department of Medical Sciences, Gastroenterology/Hepatalogy, Uppsala University, Uppsala, Sweden
    Per Hellström: Department of Medical Sciences, Gastroenterology/Hepatalogy, Uppsala University, Uppsala, Sweden
    Magnus Sundbom: Department of Surgical Sciences, Upper Abdominal Surgery, Uppsala University, Uppsala, Sweden
    Åsa Keita: Department of Clinical and Experimental Medicine (IKE) / Division of Clinical Sciences (KLINV), Linköping University, Linköping, Sweden
    Noemi Csaba: Dept. of Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Santiago de Compostela, Spain
    María José Alonso: Dept. of Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Santiago de Compostela, Spain
    Mikael Wiren: Department of Clinical and Experimental Medicine (IKE) / Division of Clinical Sciences (KLINV), Linköping University, Linköping, Sweden
    Johan Dabrosin Söderholm: Department of Clinical and Experimental Medicine (IKE) / Division of Clinical Sciences (KLINV), Linköping University, Linköping, Sweden
    Per Artursson: Department of Pharmacy, Uppsala University, Uppsala, Sweden
  • Abstract:

    Backgrounds

    Oral delivery of peptide drugs and biopharmaceutics remains a challenge. A possible way to achieve improved bioavailability of such drugs after oral administration could be to encapsulate the molecules in a nanoparticle that protects them from the harsh environment of the gastrointestinal tract and aids their penetration of the..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses